logo oncology-news

Онкология  >  Новости онкологии

При финансовой поддержке logo MSD Oncology

TNBC: Aurora A/angiogenic kinase inhibitor does well in phase 2 trial

Enrolees had locally advanced or metastatic disease after 1-3 lines of chemotherapy.